SMS Lifesciences India Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 692.61 million compared to INR 812.6 million a year ago. Revenue was INR 695.97 million compared to INR 814.09 million a year ago. Net income was INR 6.66 million compared to INR 27.52 million a year ago. Basic earnings per share from continuing operations was INR 2.2 compared to INR 9.1 a year ago.
For the six months, sales was INR 1,600.81 million compared to INR 1,635.36 million a year ago. Revenue was INR 1,610.31 million compared to INR 1,639.1 million a year ago. Net loss was INR 11.15 million compared to net income of INR 57.6 million a year ago. Basic loss per share from continuing operations was INR 3.69 compared to basic earnings per share from continuing operations of INR 19.05 a year ago.